Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Nasal sinus cancer
ADR ID BADD_A10483
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.19      Respiratory and mediastinal neoplasms malignant and unspecified
16.19.09      Paranasal sinus and nasal cavity neoplasms malignant and unspecified
16.19.09.003      Nasal sinus cancer
22      Respiratory, thoracic and mediastinal disorders
22.08      Respiratory tract neoplasms
22.08.02      Upper respiratory tract neoplasms
22.08.02.014      Nasal sinus cancer
Description Tumors or cancer of the PARANASAL SINUSES. [MeSH]
MedDRA Code 10028767
MeSH ID D010255
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Cancer of maxillary antrum | Malignant neoplasm of accessory sinus, unspecified | Malignant neoplasm of ethmoidal sinus | Malignant neoplasm of frontal sinus | Malignant neoplasm of maxillary sinus | Malignant neoplasm of other accessory sinuses | Malignant neoplasm of sphenoidal sinus | Nasal sinus cancer | Paranasal sinus cancer | Paranasal sinus cancer NOS | Squamous cell carcinoma of the paranasal sinus | Sinonasal undifferentiated carcinoma | Paranasal Sinus Neoplasms | Neoplasm, Paranasal Sinus | Paranasal Sinus Neoplasm | Neoplasms, Paranasal Sinus | Paranasal Sinus Cancer | Cancer, Paranasal Sinus | Cancers, Paranasal Sinus | Paranasal Sinus Cancers | Cancer of Paranasal Sinus
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01253Lenalidomide0.000482%
BADD_D01913Ranitidine0.000025%
The 1th Page    1    Total 1 Pages